n/a
Abstract Title:

Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.

Abstract Source:

Panminerva Med. 2021 Mar ;63(1):46-50. PMID: 33541059

Abstract Author(s):

Gianni Belcaro, Shu Hu, Maria R Cesarone, Mark Dugall, Claudia Scipione, Valeria Scipione, Morio Hosoi, Andrea Ledda, Umberto Cornelli, Beatrice Feragalli, Roberto Cotellese

Article Affiliation:

Gianni Belcaro

Abstract:

BACKGROUND: The aim of this registry study was the prospective evaluation of the efficacy of Pycnogenolin idiopathic fibromyalgia (FM), over 4 weeks in comparison with the standard management (SM).

METHODS: A SM and a Pycnogenol+SM group were formed. Pycnogenolsupplementation was used at the dose of 150 mg/day (4 weeks). The study considered the most important/frequent symptoms of FM.

RESULTS: Fifty patients with idiopathic fibromyalgia were included: 26 in the Pycnogenolgroup and 24 served as controls. The two groups were comparable at inclusion. No other disease or condition was present. All subjects were otherwise healthy women (BMI<26), not using any drug. All subjects had an elevated level of oxidative stress (OS) at inclusion. All routine blood tests - and all inflammatory and rheumatic tests - were within the normal range at inclusion and at the end of the study. No safety or tolerability problems were observed. The percentage of patients using NSAIDs (non-steroidal anti-inflammatory drugs) as rescue medications in the observation period was significantly higher in the SM management group (P<0.05) in comparison with the supplement group. The percentage of patients using corticosteroids as rescue medication was significantly higher in the SM group (P<0.05). The percentage of subjects with the symptoms/complaints decreased significantly, considering each symptom, with Pycnogenolafter 4 weeks in comparison with the SM (P<0.05).

CONCLUSIONS: Pycnogenolsupplementation appears to control and reduce the intensity of common symptoms and complaints - especially pain-related - associated with FM. Pycnogenolcould be a 'soft', safe supplementation and prevention method to manage the symptoms of most of these patients, even for longer periods, reducing the need for drugs.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.